Journal of medicinal and pharmaceutical chemistry
2010-06-24
Evolution of poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors. From concept to clinic.
Dana V Ferraris
Index: J. Med. Chem. 53 , 4561-84, (2010)
Full Text: HTML
Abstract
Related Articles:
Epigenetic reprogramming of the type III interferon response potentiates antiviral activity and suppresses tumor growth.
2014-01-01
[PLoS Biol. 12(1) , e1001758, (2014)]
Alisertib, an Aurora kinase A inhibitor, induces apoptosis and autophagy but inhibits epithelial to mesenchymal transition in human epithelial ovarian cancer cells.
2015-01-01
[Drug Des. Devel. Ther. 9 , 425-64, (2015)]
Functionalized tetrahydro-1H-pyrido[4,3-b]indoles: a novel chemotype with Sirtuin 2 inhibitory activity.
2015-03-06
[Eur. J. Med. Chem. 92 , 145-55, (2015)]
Identification and characterization of epithelial cells derived from human ovarian follicular fluid.
2015-01-01
[Stem Cell Res. Ther. 6 , 13, (2015)]
An innovative oat-based sterile emollient cream in the maintenance therapy of childhood atopic dermatitis.
2015-01-01
[Pediatr. Dermatol. 32(2) , 208-15, (2015)]